MicroRNA-674-5p induced by HIF-1α targets XBP-1 in intestinal epithelial cell injury during endotoxemia

Zhihao Liu1, Jie Jiang2, Weigang Dai3

  • 1Division of Emergency Medicine, Department of General Internal Medicine, Department of Emergency Intensive Care Unit, The First Affiliated Hospital of Sun Yat-sen University, No.58, Zhongshan 2nd Road, 510080 Guangzhou, China.

Cell Death Discovery
|June 19, 2020
PubMed

Insights

Researchers discovered that inhibiting microRNA-674-5p (miR-674-5p) protects against endotoxemia-induced intestinal injury by targeting the X-box binding protein 1 (XBP-1) pathway, improving survival in mice.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Immunology

Background:

  • Intestinal barrier dysfunction during endotoxemia contributes to sepsis development.
  • The precise mechanisms of endotoxemia-induced intestinal damage are not fully understood.

Purpose of the Study:

  • To identify key regulators of intestinal damage during endotoxemia.
  • To explore the microRNA-674-5p/X-box binding protein 1 (XBP-1) axis as a therapeutic target.

Main Methods:

  • Investigated microRNA-674-5p (miR-674-5p) and X-box binding protein 1 (XBP-1) expression in intestinal epithelial cells (IECs) during endotoxemia.
  • Utilized in vitro cell culture and in vivo mouse models of endotoxemia.
  • Assessed the impact of miR-674-5p inhibition on intestinal crypt cell proliferation, inflammation, and survival.

Main Results:

  • MiR-674-5p expression was upregulated in IECs during endotoxemia, dependent on hypoxia-inducible factor-1α (HIF-1α).
  • MiR-674-5p directly targets and downregulates XBP-1 expression.
  • Inhibition of miR-674-5p enhanced XBP-1 activity, promoted intestinal crypt cell proliferation, attenuated inflammation, and improved survival in endotoxemia mouse models.

Conclusions:

  • The miR-674-5p/XBP-1 signaling axis is a critical regulator of intestinal injury during endotoxemia.
  • Targeting this axis offers a potential therapeutic strategy for mitigating endotoxemia-induced intestinal damage and improving patient outcomes.